# Low Dose Thrombolysis, Ultrasound Assisted Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism

> **NCT04088292** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Rigshospitalet, Denmark** · enrollment: 210 (estimated)

## Conditions studied

- Pulmonary Embolism

## Interventions

- **DRUG:** Alteplase 20 Mg Powder for Solution for Injection Vial
- **DEVICE:** Ultrasound assisted Thrombolysis

## Key facts

- **NCT ID:** NCT04088292
- **Lead sponsor:** Rigshospitalet, Denmark
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-06-06
- **Primary completion:** 2024-06-05
- **Final completion:** 2024-11-30
- **Target enrollment:** 210 (ESTIMATED)
- **Last updated:** 2024-11-15

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04088292

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04088292, "Low Dose Thrombolysis, Ultrasound Assisted Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04088292. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*